Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Fall Technical MeetingFall Technical Meeting
Not Confirmed
Not Confirmed
05-07 October, 2025
The MedTech ConferenceThe MedTech Conference
Not Confirmed
Not Confirmed
05-08 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Fall Technical MeetingFall Technical Meeting
Industry Trade Show
Not Confirmed
05-07 October, 2025
The MedTech ConferenceThe MedTech Conference
Industry Trade Show
Not Confirmed
05-08 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-bridge-the-gap-between-chemistry-and-performance-to-deliver-precise-optimized-micronization-for-complex-apis
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
18 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/18/3152312/0/en/Minovia-Therapeutics-Receives-FDA-Fast-Track-Designation-for-MNV-201-in-Myelodysplastic-Syndrome.html
27 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/27/3139893/0/en/Minovia-Therapeutics-Announces-350-000-Grant-from-Countdown-for-a-Cure-Foundation-to-Develop-Mitochondria-Blood-Based-Biomarkers.html
24 Jun 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/minovia-brings-back-spac-plans-skate-icy-public-market
03 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/03/3055005/0/en/Minovia-Therapeutics-Announces-FDA-Clearance-of-Second-IND-Application-for-a-Phase-II-Clinical-Trial-of-Lead-Product-MNV-201-in-Pearson-Syndrome.html
26 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/26/2954055/0/en/Minovia-Therapeutics-Announces-FDA-Clearance-of-IND-Application-for-a-Phase-Ib-Clinical-Trial-of-MNV-201-in-Low-Risk-Myelodysplastic-Syndrome.html
05 Jan 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/01/05/2583675/0/en/Minovia-Therapeutics-appoints-Maha-Radhakrishnan-Chief-Medical-Officer-at-Biogen-as-board-member.html
ABOUT THIS PAGE